Conversational AI for HCP engagement
Doctors search ChatGPT for medical information. They don't find your MLR-approved content. They get unverified answers instead.
Doctors are searching. They're just not finding you.
of physicians say theyʼ are dissatisfied with pharma engagement, citing fragmented content and channels. (McKinsey & Company)
of HCPs feel “spammedˮ by pharma digital outreach, highlighting the need for more coordinated journeys. (Accenture)
higher sales reported within 9 months using AI-powered omni-channel campaigns for Top-10 pharma companies (Deloitte)
Your approved content isn't where doctors look
Doctors need clinical information fast. They search ChatGPT, Google, or AI tools. Your MLR-approved materials don't appear.
Information lives in PDFs
Your approved content sits in documents doctors won't search through. They need quick answers, not file downloads.
Generic AI provides unverified answers
When doctors can't find your information, they get responses from ChatGPT or search engines that aren't verified or compliant.
No visibility into what doctors need
You don't see what clinical questions doctors have, what information gaps slow prescribing, or where to focus commercial efforts.
Making your approved content accessible where doctors search
We convert your MLR-approved materials into conversational AI that doctors can search naturally, getting accurate answers from your content.
Our approach
RoseRx makes your approved content searchable through natural language. Doctors ask questions and get responses from your MLR-reviewed materials, with citations to source documents.
Who this is for
Life sciences companies with MLR-approved content who need doctors to find and use their clinical information when making prescribing decisions.
The outcome
Doctors find your approved information when they search. You see what questions they're asking in real-time, revealing what matters for prescribing decisions.
Frequently asked questions
What makes RoseRx different from a traditional HCP engagement platform?
RoseRx isn't just a HCP engagement platform - it's conversational AI that makes your approved content accessible through natural conversation. The difference: generic AI tools hallucinate medical information, RoseRx only uses your MLR-approved materials.
How does RoseRx use Agentic AI to improve pharma HCP engagement?
Is RoseRx suitable for omnichannel HCP marketing engagement?
Yes, RoseRx delivers compliant content via doctors' preferred channels including email, SMS, WhatsApp and portals. The platform traces which interactions drive prescribing decisions, showing exactly what engagement works.
Is RoseRx compliant with pharma industry regulations?
Yes, RoseRx uses MLR-approved materials only. The platform automatically detects and escalates potential adverse events in real-time, meeting pharmacovigilance requirements.
Can RoseRx personalize engagement for different HCP segments?
Yes, RoseRx tailors responses using approved content and delivers via preferred channels. The platform analyzes questions and engagement patterns to identify doctors who need specific information.
How does RoseRx improve pharma HCP engagement outcomes?
RoseRx captures doctor questions, concerns, and knowledge gaps to show what clinicians actually need. This reveals barriers to prescribing and shows commercial teams where to focus.
How does RoseRx support sales reps in HCP engagement?
RoseRx extends rep reach with compliant automated responses or personalized assistance. The platform captures leads instantly, integrates with CRM systems, and handles routine questions so reps focus on high-value interactions.
Put your approved content where doctors search
We make your MLR-approved materials accessible through conversational AI, generating commercial intelligence from every doctor question.

